Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -251.57%-2.95M | ---- | -1.22%1.95M | ---- | 752.38%1.97M | ---- | -84.33%231K | ---- | -14.25%1.47M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -11.23%-941K | ---- | -571.43%-846K | ---- | -472.73%-126K | ---- | 93.85%-22K | ---- | 46.88%-358K |
| Dividend (income)- adjustment | ---- | -0.80%-378K | ---- | 10.29%-375K | ---- | -1,293.33%-418K | ---- | ---30K | ---- | ---- |
| Impairment and provisions: | ---- | 1,114.12%1.03M | ---- | -82.58%85K | ---- | 771.43%488K | ---- | --56K | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | -41.00%118K | ---- | --200K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 231.30%151K | ---- | -123.57%-115K | ---- | 771.43%488K | ---- | --56K | ---- | ---- |
| -Other impairments and provisions | ---- | --763K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -180.04%-746K | ---- | -43.89%932K | ---- | 23.22%1.66M | ---- | --1.35M | ---- | ---- |
| -Other fair value changes | ---- | -180.04%-746K | ---- | -43.89%932K | ---- | 23.22%1.66M | ---- | --1.35M | ---- | ---- |
| Depreciation and amortization: | ---- | 3.45%3.69M | ---- | 17.25%3.56M | ---- | 22.06%3.04M | ---- | -21.08%2.49M | ---- | 35.48%3.15M |
| -Amortization of intangible assets | ---- | 16.03%1.34M | ---- | 111.36%1.15M | ---- | 21.33%546K | ---- | 614.29%450K | ---- | --63K |
| Financial expense | ---- | 194.05%247K | ---- | -26.96%84K | ---- | -8.00%115K | ---- | -34.55%125K | ---- | -24.51%191K |
| Special items | ---- | 121.60%277K | ---- | -88.67%125K | ---- | -25.72%1.1M | ---- | 167.57%1.49M | ---- | 988.24%555K |
| Operating profit before the change of operating capital | ---- | -95.86%228K | ---- | -29.60%5.51M | ---- | 37.80%7.83M | ---- | 13.28%5.68M | ---- | 32.98%5.02M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -472.69%-10.32M | ---- | 264.37%2.77M | ---- | -146.48%-1.68M | ---- | 176.07%3.62M | ---- | -207.44%-4.76M |
| Accounts payable increase (decrease) | ---- | 146.00%1.12M | ---- | -906.95%-2.44M | ---- | 120.94%302K | ---- | -184.43%-1.44M | ---- | 135.85%1.71M |
| Financial liabilities at fair value (increase)decrease | ---- | --901K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | ---- | -238.05%-8.07M | ---- | -9.38%5.84M | ---- | -18.00%6.45M | ---- | 300.97%7.86M | ---- | -43.01%1.96M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 117.41%275K | ---- | ---1.58M |
| Other taxs | ---- | 118.15%57K | ---- | -185.33%-314K | ---- | --368K | ---- | ---- | ---- | ---- |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.21%-2K |
| Special items of business | 1,174.12%2.74M | ---- | -109.69%-255K | ---- | 18.25%2.63M | ---- | 435.60%2.23M | ---- | 90.03%-663K | ---- |
| Net cash from operations | 1,174.12%2.74M | -244.85%-8.01M | -109.69%-255K | -18.88%5.53M | 18.25%2.63M | -16.24%6.82M | 435.60%2.23M | 2,047.23%8.14M | 90.03%-663K | -88.11%379K |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 44.69%858K | ---- | 370.63%593K | ---- | 472.73%126K | ---- | -93.85%22K | ---- | -46.88%358K |
| Dividend received - investment | ---- | 0.80%378K | ---- | -10.29%375K | ---- | 1,293.33%418K | ---- | --30K | ---- | ---- |
| Decrease in deposits (increase) | ---- | 31.32%-2.2M | ---- | ---3.21M | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | -26.19%-53K | ---- | 76.92%-42K | ---- | 73.04%-182K | ---- | 95.59%-675K | ---- | -20,887.67%-15.32M |
| Recovery of cash from investments | ---- | -16.96%9.64M | ---- | -5.74%11.61M | ---- | 2,184.60%12.31M | ---- | --539K | ---- | ---- |
| Cash on investment | ---- | -1.85%-13.33M | ---- | 9.42%-13.09M | ---- | 8.10%-14.45M | ---- | -743.06%-15.72M | ---- | ---1.87M |
| Other items in the investment business | 10.08%8.31M | ---- | 1,005.40%7.55M | ---- | -1,995.45%-834K | ---- | 102.52%44K | ---- | 84.08%-1.74M | ---- |
| Net cash from investment operations | 10.08%8.31M | -25.23%-4.71M | 1,005.40%7.55M | -112.06%-3.76M | -1,995.45%-834K | 88.78%-1.77M | 102.52%44K | 6.07%-15.81M | 84.08%-1.74M | -2,900.00%-16.83M |
| Net cash before financing | 51.47%11.05M | -819.86%-12.72M | 306.01%7.3M | -64.95%1.77M | -20.80%1.8M | 165.75%5.04M | 194.31%2.27M | 53.38%-7.67M | 86.33%-2.41M | -534.13%-16.45M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | ---- | -194.05%-247K | ---- | 26.96%-84K | ---- | 8.00%-115K | ---- | 33.86%-125K | ---- | ---189K |
| Other items of the financing business | -12.58%-886K | ---- | 5.52%-787K | ---- | 19.13%-833K | ---- | -591.28%-1.03M | ---- | 86.92%-149K | ---- |
| Net cash from financing operations | -12.58%-886K | 0.12%-1.69M | 5.52%-787K | -10.94%-1.69M | 19.13%-833K | -70.88%-1.53M | -591.28%-1.03M | 64.09%-893K | 86.92%-149K | -110.29%-2.49M |
| Effect of rate | -69.31%155K | 126.87%456K | 271.32%505K | 109.38%201K | 196.45%136K | -64.96%96K | -125.13%-141K | 882.86%274K | 2,034.48%561K | -172.92%-35K |
| Other items affecting net cash | ---- | ---- | ---4.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 435.85%10.17M | -19,574.32%-14.41M | 96.78%1.9M | -97.90%74K | -22.20%964K | 141.07%3.52M | 148.49%1.24M | 54.78%-8.56M | 86.36%-2.56M | -167.74%-18.94M |
| Begining period cash | -59.13%9.65M | 1.18%23.6M | 1.18%23.6M | 18.32%23.33M | 18.32%23.33M | -29.60%19.71M | -29.60%19.71M | -40.39%28M | -40.39%28M | 147.60%46.97M |
| Items Period | ---- | ---- | --4.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | -34.36%19.97M | -59.13%9.65M | 24.52%30.41M | 1.18%23.6M | 17.37%24.43M | 18.32%23.33M | -19.98%20.81M | -29.60%19.71M | -7.79%26.01M | -40.39%28M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Kadoorie Certified Public Accountants Ltd | -- | Kadoorie Certified Public Accountants Ltd | -- | Kadoorie Certified Public Accountants Ltd | -- | Kadoorie Certified Public Accountants Ltd | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.